Abstract
Objectives To determine the role of the B-cell attracting chemokine CXCL-13, which may initiate B-cell trafficking and IgM production in diagnosing HAT meningo-encephalitis. Methods We determined CXCL-13 levels by ELISA on paired sera and CSF of 26 patients from Angola and of 16 controls (six endemic and ten non-endemic). Results were compared to standard stage determination markers and IgM intrathecal synthesis. Results CXCL-13 levels in patients' sera had a median value of 386.6 pg/ml and increased levels were associated with presence of trypanosomes in the CSF but not with other stage markers. CXCL-13 levels in patients' CSF had a median value of 80.9 pg/ml and increased levels were associated with all standard stage determination markers and IgM intrathecal synthesis. Conclusion CXCL-13 levels in CSF increased significantly during the course of HAT. Hence the value of CXCL-13 for diagnosis, follow-up or as a marker of disease severity should be tested in a well-defined cohort study. © 2009 Blackwell Publishing Ltd.
Author supplied keywords
Cite
CITATION STYLE
Courtioux, B., Pervieux, L., Vatunga, G., Marin, B., Josenando, T., Jauberteau-Marchan, M. O., … Bisser, S. (2009). Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis. Tropical Medicine and International Health, 14(5), 529–534. https://doi.org/10.1111/j.1365-3156.2009.02263.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.